Evidence map›Paper›PMID 35313843›Full record

ArticleBMC public health2022

Willingness and uptake of the COVID-19 testing and vaccination in urban China during the low-risk period: a cross-sectional study.

Suhang Song, Shujie Zang, Liubing Gong, Cuilin Xu, Leesa Lin, Mark R Francis, Zhiyuan Hou

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Review
  13. Article
  14. Article
  15. COVID-19 self-testing in Brazil and the imminent risk of underreporting cases.Revista da Sociedade Brasileira de Medicina Tropical · 2023
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 4 countries.

Suhang SongTaub Institute for Research in Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY, USA.
Shujie ZangSchool of Public Health, Fudan University, Shanghai, China.
Liubing GongChizhou Center for Disease Prevention and Control, Chizhou, Anhui province, China.
Cuilin XuYuhuatai Center for Disease Prevention and Control, Nanjing, China.
Leesa LinDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Mark R FrancisHealth Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Zhiyuan HouSchool of Public Health, Fudan University, Shanghai, China. zyhou@fudan.edu.cn.
Chizhou University · CNColumbia University · USFudan University · CNLondon School of Hygiene & Tropical Medicine · GBNanjing Municipal Center for Disease Control And Prevention · CNNational Health and Family Planning Commission · CNTampere University · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRegular testing and vaccination are effective measures to mitigate the ongoing COVID-19 pandemic. Evidence on the willingness and uptake of the COVID-19 testing is scarce, and the willingness and uptake of vaccination may change as the pandemic evolves. This study aims to examine willingness and uptake of COVID-19 testing and vaccination during a low-risk period of the COVID-19 pandemic in urban China.

methodsA cross-sectional online survey was conducted among 2244 adults in urban China. Descriptive analyses were performed to compare the respondents' willingness and uptake of COVID-19 testing and vaccination. Multivariate logistic regressions were fitted to investigate factors associated with the willingness and uptake of the two measures.

resultsIn early 2021, about half (52.45%) of the respondents had received or scheduled a COVID-19 test at least once, and a majority (95.63%) of the respondents were willing to receive testing. About two-thirds (63.28%) of the respondents had received/scheduled or were willing to receive a COVID-19 vaccine. Willingness and uptake of COVID-19 testing were not associated with socio-demographic characteristics, except for occupation. Being of older age, migrants, having higher educational attainment and secure employment were associated with a higher uptake of COVID-19 vaccination among the surveyed respondents, while willingness to vaccinate was consistent across socio-demographic characteristics among those who had not been vaccinated.

conclusionsBy early 2021, Chinese adults expressed almost universal willingness of COVID-19 testing and over half of adults have been tested, while the willingness and uptake of COVID-19 vaccination were relatively low at the low-risk period of the COVID-19 pandemic. Maintaining willingness of COVID-19 vaccination is critical and necessary, especially when the pandemic evolved into a low-risk period.

Indexed as

COVID-19Influenza, HumanInfluenza VaccinesAdultChinaCOVID-19 TestingCOVID-19 VaccinesCross-Sectional StudiesHumansPandemicsVaccinationCOVID-19 VaccinesInfluenza VaccinesCOVID-19 testingCOVID-19 vaccinationUptakeWillingness

Identifiers

PMID35313843
PMCPMC8935604
OpenAlexW4221131082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.